What are the imaging washout characteristics of pheochromocytoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pheochromocytomas are best distinguished from adrenal adenomas by their delayed washout on contrast-enhanced CT imaging, with washout values typically less than 60% at 15 minutes, as opposed to adrenal adenomas which show rapid washout of contrast (>60% absolute washout at 15 minutes) 1.

Key Imaging Characteristics

  • Pheochromocytomas characteristically appear bright on T2-weighted MRI images due to their high fluid content, known as the "light bulb" sign.
  • The gold standard for functional imaging of pheochromocytomas is 123I-MIBG (metaiodobenzylguanidine) scintigraphy, which has high specificity as it is taken up by catecholamine-producing cells.
  • PET imaging with 18F-FDG or more specific tracers like 18F-FDOPA and 68Ga-DOTATATE can also be valuable, particularly for metastatic disease.

Limitations of Washout CT

  • Roughly 1/3 of pheochromocytomas may washout in the characteristic range of an adenoma.
  • Approximately 1/3 of adrenal adenomas do not washout in the adenoma range.
  • Malignant masses can also washout in the adenoma range, which can result in adrenal cortical carcinoma or hyper-vascular metastases being mistaken for an adenoma on a CT washout.

Alternative Imaging Options

  • Chemical shift MRI can be used as an alternative to washout CT, exploiting the different frequency of protons in water and fat to detect microscopic fat.
  • When microscopic fat is identified as a homogeneous signal intensity drop on MRI, these features are diagnostic of lipid-rich adenoma.
  • Heterogeneous signal intensity drop is a more controversial imaging finding since minute amounts of microscopic fat have been identified in pheochromocytoma, adrenal cortical carcinoma, and some metastases 1.

From the Research

Pheochromocytoma Imaging Washout Characteristics

  • Pheochromocytomas can have variable imaging appearances, including low attenuation on unenhanced CT and high percentage of contrast washout on delayed scanning, which can mimic adrenal adenomas 2, 3.
  • The washout pattern of pheochromocytomas can be inconsistent, with some studies showing a high percentage of contrast washout, while others demonstrate a more variable washout profile 2, 4.
  • A systematic review and meta-analysis found that 35% of pheochromocytomas met the criteria for adenomas on adrenal washout CT, highlighting the potential for false positives 4.
  • The diagnostic performance of adrenal washout CT for differentiating adenoma from pheochromocytoma showed good sensitivity (97%) but relatively low specificity (67%) 4.
  • Other imaging modalities, such as positron emission tomography, have been shown to be effective in localizing pheochromocytomas, particularly in cases where conventional imaging modalities are inconclusive 5.

Key Findings

  • Pheochromocytomas can exhibit a range of imaging appearances, making diagnosis challenging 3, 6.
  • Adrenal washout CT can be used to characterize pheochromocytomas, but its specificity is relatively low 4.
  • A combination of imaging modalities and clinical correlation is necessary for accurate diagnosis of pheochromocytomas 2, 3, 6, 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma.

AJR. American journal of roentgenology, 2003

Research

Pheochromocytoma: an imaging chameleon.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.